BRPI0620425B8 - composição para nutrição parenteral, método para preparar a mesma, uso, e, kit - Google Patents
composição para nutrição parenteral, método para preparar a mesma, uso, e, kitInfo
- Publication number
- BRPI0620425B8 BRPI0620425B8 BRPI0620425A BRPI0620425A BRPI0620425B8 BR PI0620425 B8 BRPI0620425 B8 BR PI0620425B8 BR PI0620425 A BRPI0620425 A BR PI0620425A BR PI0620425 A BRPI0620425 A BR PI0620425A BR PI0620425 B8 BRPI0620425 B8 BR PI0620425B8
- Authority
- BR
- Brazil
- Prior art keywords
- kit
- preparing
- parenteral nutrition
- same
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000016236 parenteral nutrition Nutrition 0.000 title abstract 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
- 229910052742 iron Inorganic materials 0.000 abstract 2
- SXAWSYZURCZSDX-UHFFFAOYSA-B hydron;[hydroxy(oxido)phosphoryl] hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylate;iron(3+);phosphonato phosphate Chemical compound [H+].[H+].[H+].[H+].[H+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].OP([O-])(=O)OP(O)([O-])=O.OP([O-])(=O)OP(O)([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O SXAWSYZURCZSDX-UHFFFAOYSA-B 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75381505P | 2005-12-23 | 2005-12-23 | |
US60/753815 | 2005-12-23 | ||
US60/753,815 | 2005-12-23 | ||
PCT/US2006/048772 WO2007075877A2 (en) | 2005-12-23 | 2006-12-22 | Parenteral nutrition composition containing iron |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0620425A2 BRPI0620425A2 (pt) | 2011-11-08 |
BRPI0620425B1 BRPI0620425B1 (pt) | 2021-04-06 |
BRPI0620425B8 true BRPI0620425B8 (pt) | 2021-06-22 |
Family
ID=38218605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0620425A BRPI0620425B8 (pt) | 2005-12-23 | 2006-12-22 | composição para nutrição parenteral, método para preparar a mesma, uso, e, kit |
Country Status (14)
Country | Link |
---|---|
US (1) | US9161951B2 (pt) |
EP (1) | EP1973552B1 (pt) |
JP (1) | JP5191397B2 (pt) |
CN (2) | CN101384295B (pt) |
AU (1) | AU2006331590B2 (pt) |
BR (1) | BRPI0620425B8 (pt) |
CA (1) | CA2634751C (pt) |
DK (1) | DK1973552T3 (pt) |
ES (1) | ES2634142T3 (pt) |
HK (1) | HK1126149A1 (pt) |
MX (1) | MX2008008009A (pt) |
PT (1) | PT1973552T (pt) |
RU (1) | RU2427364C2 (pt) |
WO (1) | WO2007075877A2 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7816404B2 (en) * | 2007-07-20 | 2010-10-19 | Rockwell Medical Technologies, Inc. | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions |
US7658952B2 (en) * | 2007-10-11 | 2010-02-09 | Baxter International Inc. | Dialysis solutions containing pyrophosphates |
US20090124572A1 (en) * | 2007-11-09 | 2009-05-14 | Deanna Jean Nelson | Iron-containing nutritional supplement |
EP2288337A1 (en) * | 2008-05-07 | 2011-03-02 | University of Lausanne | Parenteral supplement with traceelem ntsfor treatment of i. a. sirs, burns selenium-defenciencies |
US8993625B2 (en) | 2009-03-11 | 2015-03-31 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
US9034389B2 (en) * | 2009-03-11 | 2015-05-19 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
EP2497380A1 (en) * | 2011-03-10 | 2012-09-12 | DSM IP Assets B.V. | Process for iron supplementation of beverages |
ITMI20121351A1 (it) * | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione liquida a base di ferro per uso nelle condizioni di deficienza di ferro. |
ITMI20121350A1 (it) * | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
JP2016507527A (ja) * | 2013-02-01 | 2016-03-10 | チャラク エルエルシー | 可溶性ピロリン酸第二鉄を用いて鉄欠乏症を治療する方法 |
WO2014193821A1 (en) * | 2013-05-28 | 2014-12-04 | Momenta Pharmaceuticals, Inc. | Pharmaceutical compositions comprising pyrophosphate |
ITMI20131483A1 (it) | 2013-09-09 | 2015-03-10 | Alesco Srl | Composizioni in forma solida a base di minerali e formulazioni orosolubili contenenti le stesse. |
WO2016037836A1 (en) * | 2014-09-08 | 2016-03-17 | Unilever N.V. | Iron-fortified edible oil-and-water emulsion |
IT201700085412A1 (it) * | 2017-07-26 | 2019-01-26 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
US20220378077A1 (en) * | 2021-05-25 | 2022-12-01 | Baxter International Inc. | Ready-To-Use Parenteral Nutrition Formulation |
WO2023205635A1 (en) * | 2022-04-19 | 2023-10-26 | Vanderbilt University | Compositions and methods of treatment for congenital diarrheal disorder |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3530216A (en) | 1967-10-05 | 1970-09-22 | Hoffmann La Roche | Vitamin compositions comprising riboflavin-5-phosphate and ferric pyrophosphate soluble |
US4329332A (en) * | 1978-07-19 | 1982-05-11 | Patrick Couvreur | Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them |
US4315942A (en) | 1979-05-21 | 1982-02-16 | New England Medical Center, Inc. | Intravenously administrable iron supplement |
US4753963A (en) | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
US4867963A (en) | 1987-01-29 | 1989-09-19 | Temple University Of The Commonwealth System Of Higher Education | Enhancement of NMR imaging of tissue by paramagnetic pyrophosphate contrast agent |
US5447732A (en) | 1992-11-25 | 1995-09-05 | Ajinomoto Co., Inc. | High-absorption mineral-containing composition and foods |
JP2990686B2 (ja) | 1994-11-17 | 1999-12-13 | 田辺製薬株式会社 | 水溶性ビタミンb類配合総合輸液 |
US6689275B1 (en) | 1996-12-31 | 2004-02-10 | Ajay Gupta | Method and pharmaceutical composition for replacing iron losses in dialysis patients |
US6779468B1 (en) * | 1997-08-07 | 2004-08-24 | Ajay Gupta | Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
WO1999007419A1 (en) | 1997-08-07 | 1999-02-18 | Ajay Gupta | Dialysis solutions containing water soluble vitamins and nutrients |
JP4717170B2 (ja) * | 1998-08-31 | 2011-07-06 | ニプロ株式会社 | 栄養輸液製剤 |
DE69929128T2 (de) * | 1998-08-31 | 2006-06-29 | Nipro Corp. | Nährstoffinfusionspräparat |
AU6605100A (en) | 1999-06-30 | 2001-01-31 | Ajay Gupta | Method and pharmaceutical composition for parenteral administration of iron |
IN186588B (pt) * | 1999-07-28 | 2001-10-06 | Vinod Daftary Gautam Dr | |
US6960571B2 (en) * | 2003-03-14 | 2005-11-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
CA2545752C (en) | 2003-11-12 | 2013-03-26 | Children's Medical Center Corporation | Treatment and prevention of liver disease associated with parenteral nutrition (pn) |
-
2006
- 2006-12-22 CN CN200680052611.4A patent/CN101384295B/zh not_active Expired - Fee Related
- 2006-12-22 BR BRPI0620425A patent/BRPI0620425B8/pt not_active IP Right Cessation
- 2006-12-22 US US11/644,527 patent/US9161951B2/en active Active
- 2006-12-22 CA CA2634751A patent/CA2634751C/en active Active
- 2006-12-22 DK DK06847907.0T patent/DK1973552T3/en active
- 2006-12-22 WO PCT/US2006/048772 patent/WO2007075877A2/en active Application Filing
- 2006-12-22 CN CN2012102156458A patent/CN102861336A/zh active Pending
- 2006-12-22 ES ES06847907.0T patent/ES2634142T3/es active Active
- 2006-12-22 AU AU2006331590A patent/AU2006331590B2/en not_active Ceased
- 2006-12-22 RU RU2008130417/15A patent/RU2427364C2/ru active
- 2006-12-22 JP JP2008547542A patent/JP5191397B2/ja not_active Expired - Fee Related
- 2006-12-22 PT PT68479070T patent/PT1973552T/pt unknown
- 2006-12-22 EP EP06847907.0A patent/EP1973552B1/en active Active
- 2006-12-22 MX MX2008008009A patent/MX2008008009A/es active IP Right Grant
-
2009
- 2009-05-19 HK HK09104539.1A patent/HK1126149A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2427364C2 (ru) | 2011-08-27 |
BRPI0620425A2 (pt) | 2011-11-08 |
CN101384295B (zh) | 2014-10-29 |
ES2634142T3 (es) | 2017-09-26 |
MX2008008009A (es) | 2008-09-12 |
EP1973552B1 (en) | 2017-04-12 |
HK1126149A1 (en) | 2009-08-28 |
JP2009521466A (ja) | 2009-06-04 |
BRPI0620425B1 (pt) | 2021-04-06 |
AU2006331590A1 (en) | 2007-07-05 |
US9161951B2 (en) | 2015-10-20 |
CN102861336A (zh) | 2013-01-09 |
AU2006331590B2 (en) | 2012-07-26 |
DK1973552T3 (en) | 2017-08-07 |
CN101384295A (zh) | 2009-03-11 |
US20070148259A1 (en) | 2007-06-28 |
WO2007075877A3 (en) | 2007-12-06 |
JP5191397B2 (ja) | 2013-05-08 |
CA2634751C (en) | 2017-10-31 |
EP1973552A2 (en) | 2008-10-01 |
RU2008130417A (ru) | 2010-01-27 |
EP1973552A4 (en) | 2012-02-29 |
PT1973552T (pt) | 2017-07-18 |
WO2007075877A2 (en) | 2007-07-05 |
CA2634751A1 (en) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0620425B8 (pt) | composição para nutrição parenteral, método para preparar a mesma, uso, e, kit | |
BRPI0511771A (pt) | formulações nutricionais | |
MY152283A (en) | Polo-like kinase inhibitirs | |
UY32049A (es) | Inhibidores de cmet | |
TW200801001A (en) | Compounds | |
TW200736263A (en) | Compounds | |
ECSP10010688A (es) | Activadores de glucoquinasa | |
IL187586A0 (en) | Method for producing dihydroquinazolines | |
ZA200906032B (en) | 3-amino-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h)carbaldehyde derivatives as pkc inhibitors | |
PA8779101A1 (es) | "compuestos tricíclicos como inhibidores de metaloproteinasas matriciales" | |
GB0613208D0 (en) | Compounds | |
TW200714281A (en) | Novel compounds | |
RS53745B1 (en) | 6-AMINO-2 - {[(1S) -1-METYLBUTIL] OKSI} -9- [5- (1-PIPERIDINIL) PENTIL] -7,9-DIHIDRO-8H-PURIN-8-ON-MALEAT | |
UY29857A1 (es) | Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica. | |
MX2009013515A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica. | |
MX2010002245A (es) | Derivados de ariloxiacetamida bi o triciclicos, saturados e insaturados y su uso como fungicidas. | |
EP2048280A4 (en) | ARTificial leather, carrier material therefor and any manufacturing methods | |
CR9853A (es) | Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion | |
AR048167A1 (es) | Suplemento dietetico con cantidades estequiometricamente especificas de citrato de potasio y magnesio | |
ZA201003970B (en) | Shading composition | |
AU318228S (en) | Lighting fixture | |
AU303865S (en) | Left boot | |
AU303867S (en) | Left boot | |
AU300621S (en) | DIY petwash station | |
AU314525S (en) | Hand-shower holder for hand-rail |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE A DESPACHO 8.6 NA RPI 2161 DE 05/06/2012. |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B09X | Republication of the decision to grant [chapter 9.1.3 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/12/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2703 DE 25-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |